GlassScriptPhysician profile
Bryan D Strickland
NPI 1528042017
$1,818.80
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $249 · 2021: $303 · 2022: $218 · 2023: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $363.60 | 2019-2023 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.58 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $221.92 | 2019-2023 | Zerbaxa, Dificid, Recarbrio |
| Pfizer INC. | $142.06 | 2019-2022 | |
| Glaxosmithkline, LLC. | $134.69 | 2021-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $100.05 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $86.10 | 2019-2021 | |
| Astellas Pharma US INC | $66.43 | 2019 | |
| Sanofi-Aventis U.S. LLC | $65.76 | 2019 | |
| Lilly USA, LLC | $59.30 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.97 | 2019-2022 | |
| Amarin Pharma, INC. | $57.04 | 2019-2020 | |
| Abbvie INC. | $41.61 | 2021-2023 | Avycaz |
| Abbott Laboratories | $30.30 | 2022-2023 | Freestyle Libre 3 |
| Dexcom, INC. | $28.46 | 2023 | Dexcom G6 Transmitter |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $20.16 | 2019 | |
| Ibsa Pharma INC. | $17.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.98 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Strickland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.